Aneuploidy in human cancer: new tools and perspectives

Trends Genet. 2023 Sep 29:S0168-9525(23)00219-6. doi: 10.1016/j.tig.2023.09.002. Online ahead of print.ABSTRACTChromosome copy number imbalances, otherwise known as aneuploidies, are a common but poorly understood feature of cancer. Here, we describe recent advances in both detecting and manipulating aneuploidies that have greatly advanced our ability to study their role in tumorigenesis. In particular, new clustered regularly interspaced short palindromic repeats (CRISPR)-based techniques have been developed that allow the creation of isogenic cell lines with specific chromosomal changes, thereby facilitating experiments in genetically controlled backgrounds to uncover the consequences of aneuploidy. These approaches provide increasing evidence that aneuploidy is a key driver of cancer development and enable the identification of multiple dosage-sensitive genes encoded on aneuploid chromosomes. Consequently, measuring aneuploidy may inform clinical prognosis, while treatment strategies that target aneuploidy could represent a novel method to counter malignant growth.PMID:37778926 | DOI:10.1016/j.tig.2023.09.002
Source: Trends in Genetics : TIG - Category: Genetics & Stem Cells Authors: Source Type: research